Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21972386.
- Also identified by DOI 10.1378/chest.10-2588.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of pulmonary arterial hypertension (PAH) occurring in a patient with Cowden syndrome with a mutation in the phosphatase and tensin (PTEN) tumor suppressor gene, in the context of exposure to the appetite suppressant dexfenfluramine. Anorexigen exposure is known to be a risk factor for PAH. However, the role of PTEN in cell function and the development of pulmonary vascular remodeling and histopathologic signs of PAH in mice with a Pten depletion in smooth muscle cells suggest that the association of PAH and Cowden syndrome may be relevant. In this case report, we hypothesize that PTEN mutations may be a predisposing factor for the development of PAH, with anorexigen exposure as a potential trigger.
Medical subject headings
- Appetite Depressants
- Hamartoma Syndrome, Multiple
- Hypertension, Pulmonary